Skip to content

Metabolic Access

Home
About
Contact

Metabolic health, clearly explained

Clear costs, coverage, and evidence for modern metabolic care.

GLP-1 Muscle Loss: What Lean Mass and Strength Studies Actually Show

Lean-mass loss, skeletal muscle, and strength are different outcomes. A source-linked comparison of semaglutide, tirzepatide, exercise, and the questions worth asking at follow-up. Read article →

October 15, 2026
Can Pendulum Probiotics Help With GLP-1, Weight Loss, or Weight Regain?

A neutral, formula-specific look at Pendulum probiotics: what human research says about glucose, cravings, Akkermansia, and weight regain after GLP-1 treatment. Read article →

October 14, 2026
Autism, Probiotics, and the Gut Microbiome: What Human Trials Actually Show

Human trials of probiotics in autism report mixed results. This review separates gut symptoms, daily functioning, butyrate hypotheses, and digital tracking. Read article →

October 10, 2026
Walking After Meals for Blood Sugar: What Timing Trials Really Show

Seven randomized crossover trials separate postmeal walking timing, short-term glucose changes, and longer-term HbA1c outcomes. Includes null findings and source-access limits. Read article →

October 8, 2026
Akkermansia for Weight-Loss Maintenance: What Human Trials Show

A human trial suggests a specific pasteurized Akkermansia preparation may help limit weight regain. We compare the evidence, product differences, and unanswered GLP-1 questions. Read article →

October 5, 2026
Medicare Open Enrollment 2027: A Checklist for Diabetes and GLP-1 Care

Prepare for 2027 Medicare coverage with an eight-step checklist for prescriptions, pharmacies, yearly costs, prior authorization, and GLP-1 Bridge rules. Includes a comparison worksheet and a call script to resolve coverage questions before switching. Read article →

October 1, 2026
The Gut Microbiome and Gut Health: How Butyrate May Shape the Intestinal Environment

Butyrate may help shape the gut environment, but promising microbiome findings are not proof of supplement benefits. We examine a new human study, its limits, and what a comparison with fermented SCFA preparations would need to test. Read article →

September 30, 2026
Butyrate for Pediatric IBD: Why Two Trials Reached Different Answers

A parent-focused comparison of two pediatric butyrate trials, explaining conflicting remission results, reporting inconsistencies, and why study doses are not prescriptions. Read article →

September 28, 2026
Butyrate Probiotics and Pouchitis: Why the Exact Strain and Treatment Goal Matter

A practical US guide to strain-specific probiotic evidence, separating first-episode pouchitis prevention, recurrence prevention, and ulcerative colitis treatment. Read article →

September 28, 2026
Butyrate for Ulcerative Colitis: What the Clinical Trials Really Show

An evidence review of oral butyrate in adult ulcerative colitis: what improved, what did not, and why newer Crohn’s research still needs careful interpretation. Read article →

September 28, 2026

Metabolic Access

Clear costs, coverage, and evidence for modern metabolic care.

About
Editorial Policy
Medical Disclaimer
Privacy Policy
Contact

Evidence-aware information for modern metabolic care. For general education only; not a substitute for personal medical advice.

© 2026 Metabolic Access

Manage Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}